General Peptide Reconstitution & Handling Safety — Peptides
Evidence-based guide covering sterile reconstitution technique, BAC water usage, storage requirements, injection site safety, expiry management, and contamination prevention for lyophilized peptides.
Overview
Lyophilized (freeze-dried) peptides require reconstitution before administration. The process involves dissolving the lyophilized powder in a suitable sterile diluent — most commonly bacteriostatic water (sterile water for injection containing 0.9% benzyl alcohol) — using aseptic technique to prevent contamination. Bacteriostatic water (BAC water) is the preferred diluent for multi-dose vials because benzyl alcohol inhibits microbial growth, extending the stability window of the reconstituted solution to approximately 28–30 days when refrigerated at 2–8°C. Sterile water for injection (SWFI) without preservative is an acceptable alternative but should be used within 24–48 hours of reconstitution as it lacks antimicrobial protection. Acetic acid (0.1–1% solution) is used for specific peptides that are poorly soluble in neutral pH, such as GHK-Cu. The reconstitution volume determines the final peptide concentration and therefore the injection volume per dose — clinicians must calculate this accurately to avoid dosing errors. Lyophilized powder should be stored at −20°C (−4°F) for long-term storage (≥6 months) or at 2–8°C (36–46°F) for short-term use. Once reconstituted, peptide solutions are far less stable than the lyophilized form and must be refrigerated continuously. Proper injection technique — subcutaneous (SC) for most peptides, intramuscular (IM) for select preparations — minimizes local reactions and reduces the risk of infection. Site rotation is essential to prevent lipohypertrophy and ensure consistent absorption.
Indications
- Required pre-administration guidance for all lyophilized injectable peptides (BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, AOD 9604, Epithalon, etc.)
- Multi-dose vial management with bacteriostatic water
- Subcutaneous and intramuscular peptide injection preparation
- Long-term peptide storage management (pre- and post-reconstitution)
- Contamination prevention in compounded peptide preparations
Mechanism of Action
Pharmaceutical peptides are freeze-dried (lyophilized) to remove water content, reducing molecular mobility and preventing hydrolysis, oxidation, and aggregation. The dry solid form is stable for months to years at appropriate temperatures.
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Lyophilized peptide (e.g., BPC-157 5 mg) | Add 2.5 mL BAC water | One-time reconstitution | Yields 2 mg/mL concentration; 100 mcg dose = 0.05 mL (5 units on U-100 insulin syringe) |
| Lyophilized peptide (e.g., CJC-1295 2 mg) | Add 2 mL BAC water | One-time reconstitution | Yields 1 mg/mL; 100 mcg dose = 0.10 mL (10 units on U-100 syringe) |
| Lyophilized peptide (e.g., Ipamorelin 5 mg) | Add 2.5 mL BAC water | One-time reconstitution | Yields 2 mg/mL; 200 mcg dose = 0.10 mL (10 units on U-100 syringe) |
| Most peptides (BPC-157, TB-500, GHRPs) | Per compound protocol | Per compound protocol | Pinch skin, 45° or 90° angle, abdomen/thigh preferred sites; 27–31 gauge insulin syringe |
| Select peptides where IM is specified | Per compound protocol | Per compound protocol | 22–25 gauge needle, 1–1.5 inch; deltoid or gluteal preferred; aspirate not required for IM peptide injections |
Safety & Contraindications
- NEVER use tap water, distilled water, or saline as the diluent — only sterile bacteriostatic water (BAC water), sterile water for injection, or pharmaceutical-grade acetic acid solutions
- Reconstituted peptide solutions must be refrigerated continuously at 2–8°C — never leave at room temperature for extended periods
- Discard reconstituted solution after 28–30 days (BAC water) or 24–48 hours (sterile water without preservative) regardless of remaining volume
- Inspect the vial before every injection: discard if the solution is cloudy, discolored, contains visible particles, or shows any sign of contamination
- Use a new sterile needle and syringe for every injection — never reuse needles
- Wipe all vial stoppers with 70% isopropyl alcohol swabs before every penetration
- Benzyl alcohol (present in BAC water) is contraindicated in neonates and premature infants — do not use BAC water in pediatric settings
- Multi-dose vials should be limited to one patient per vial to prevent cross-contamination
- Rotate injection sites systematically to prevent lipohypertrophy, scar tissue formation, and absorption variability
- Do not inject into infected, bruised, tattooed, or scarred skin areas